Richard S. Geary, EVP, Chief Development Officer at IONIS PHARMACEUTICALS INC (IONS), sold 115,800 shares at $65.24 ($7.6M) on 2025-09-30, disclosed to the SEC on 2025-10-01.
Scheduled sale ($7.6M) by EVP, Chief Development Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $65.24 | 57,900 | $3.8M | 50.0% |
| 2 | $65.24 | 57,900 | $3.8M | 50.0% |
| Total | $65.24 avg | 115,800 | $7.6M | 100% |
| Filing → |
| IONS | SELL | 2025-11-03 | $11.9M | — | Filing → |
| IONS | SELL | 2025-09-04 | $504K | — | Filing → |
| IONS | SELL | 2025-08-06 | $429K | — | Filing → |